Agasti 2023: Inhlanganisela yomthamo ongaguquki we-niraparib ne-abiraterone acetate (Akeega, Janssen Biotech, Inc.), kanye ne-prednisone, kugunyazwe i-Food and Drug Administration ezigulini ezikhulile ezine-castration-resista.
Agasti 2022: Amaphilisi e-Darolutamide (Nubeqa, Bayer HealthCare Pharmaceuticals Inc.) ahlanganiswe ne-docetaxel agunyazwa i-Food and Drug Administration ezigulini ezikhulile ezinomdlavuza we-prostate we-metastatic-sensitive hormone (mHS..
Ephreli 2022: Ukuphathwa Kwezokudla Nezidakamizwa kugunyaze i-Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced Accelerator Applications USA, Inc., inkampani yakwaNovartis) ukuze kulashwe iziguli ezikhulile ezine-prostate-specific mem.
Mashi 2022: I-HIFU (I-High Intensity Focused Ultrasound) iwukwelapha okuhlaba umxhwele esebenzisa amagagasi agxilile, anamandla amakhulu we-ultrasound ukushisa nokubulala izingxenye ezinomdlavuza zendlala yesinye. Izicubu eziqondiwe zishisiswe zibe ngama-880 kuya ku-980 degrees.
Agasti 2021: I-oral gonadotropin-releasing hormone (GnRH) receptor antagonist, i-relugolix (ORGOVYX, Myovant Sciences, Inc.), yamukelwa yi-Food and Drug Administration ngoDisemba 18, 2020, yeziguli ezindala ezihlangene ..